LAKE OSWEGO, Ore-- BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope ...
Biotronik announced 2 new studies last week that are slated to examine the company’s CRT-D device and BioMonitor implanted cardiac monitor. A 277-patient BioContinue clinical trial will examine the ...
The BIOMONITOR IIIm improves patient outcomes with its clinically actionable ECGs, superior features, and high precision LONDON, July 28, 2021 /PRNewswire/ -- Based on its recent analysis of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results